Total Payments
$8,515
2024 Payments
$918.80
Companies
35
Transactions
438
Medicare Patients
8,892
Medicare Billing
$804,621
Payment Breakdown by Category
Food & Beverage$8,119 (95.3%)
Education$396.00 (4.7%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,119 | 434 | 95.3% |
| Education | $396.00 | 4 | 4.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABIOMED | $1,309 | 23 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,222 | 82 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,013 | 92 | $0 (2024) |
| Medtronic, Inc. | $945.77 | 20 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $526.44 | 80 | $0 (2024) |
| Boston Scientific Corporation | $418.08 | 9 | $0 (2022) |
| Medtronic Vascular, Inc. | $368.21 | 9 | $0 (2020) |
| Abbott Laboratories | $337.98 | 7 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $271.95 | 10 | $0 (2024) |
| Astellas Pharma US Inc | $267.66 | 5 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $918.80 | 57 | Novartis Pharmaceuticals Corporation ($342.04) |
| 2023 | $1,183 | 78 | Novartis Pharmaceuticals Corporation ($391.96) |
| 2022 | $1,682 | 79 | Medtronic, Inc. ($661.80) |
| 2021 | $991.36 | 52 | Astellas Pharma US Inc ($215.60) |
| 2020 | $722.98 | 28 | ABIOMED ($382.86) |
| 2019 | $917.05 | 56 | ABIOMED ($439.85) |
| 2018 | $1,377 | 55 | Medtronic Vascular, Inc. ($343.69) |
| 2017 | $721.87 | 33 | Abbott Laboratories ($190.13) |
All Payment Transactions
438 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $31.81 | General |
| Category: Heart Failure and Hypertension | ||||||
| 12/04/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $26.00 | General |
| Category: Cardiology | ||||||
| 12/04/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $6.93 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/02/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $15.64 | General |
| Category: Cardiology | ||||||
| 11/07/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/05/2024 | ATRICURE, INC. | SYNERGY ABLATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/05/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $4.14 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $3.27 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/04/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/29/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/03/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $6.37 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/01/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/18/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.02 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/13/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $8.08 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/12/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $26.91 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/12/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $3.72 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/14/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $11.27 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/05/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $8.57 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/30/2024 | ATRICURE, INC. | SYNERGY ABLATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.96 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $12.60 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/17/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/14/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 2,428 | 3,529 | $605,417 | $226,647 |
| 2022 | 23 | 1,677 | 2,171 | $425,825 | $154,973 |
| 2021 | 29 | 2,280 | 2,971 | $552,644 | $209,671 |
| 2020 | 35 | 2,507 | 3,172 | $569,328 | $213,330 |
Total Patients
8,892
Total Services
11,843
Medicare Billing
$804,621
Procedure Codes
127
All Medicare Procedures & Services
127 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 424 | 571 | $145,332 | $52,369 | 36.0% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 170 | 559 | $69,316 | $27,713 | 40.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 129 | 194 | $44,112 | $18,120 | 41.1% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 51 | 51 | $43,754 | $17,315 | 39.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 132 | 135 | $35,775 | $14,072 | 39.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 95 | 95 | $36,510 | $13,891 | 38.0% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 165 | 315 | $29,295 | $11,766 | 40.2% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 51 | 102 | $22,950 | $9,216 | 40.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 127 | 156 | $28,032 | $9,124 | 32.5% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 46 | 184 | $22,512 | $7,563 | 33.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 141 | 142 | $19,425 | $7,413 | 38.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 83 | 104 | $16,079 | $6,598 | 41.0% |
| G0506 | Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) | Office | 2023 | 135 | 138 | $16,836 | $6,563 | 39.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 59 | 59 | $19,727 | $6,547 | 33.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 33 | 33 | $12,677 | $4,593 | 36.2% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 18 | 18 | $10,926 | $3,569 | 32.7% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 63 | 63 | $8,757 | $3,085 | 35.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 151 | 161 | $4,669 | $1,776 | 38.0% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 24 | 24 | $3,656 | $1,442 | 39.4% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 155 | 176 | $5,648 | $1,130 | 20.0% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 25 | 59 | $2,655 | $952.62 | 35.9% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 24 | 24 | $1,024 | $384.56 | 37.6% |
| 85610 | Blood test, clotting time | Office | 2023 | 27 | 65 | $585.00 | $273.00 | 46.7% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 14 | 14 | $1,372 | $262.22 | 19.1% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 24 | 24 | $680.00 | $255.30 | 37.5% |
About Dr. Mukesh Kumar, MD
Dr. Mukesh Kumar, MD is a Cardiovascular Disease healthcare provider based in Kissimmee, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1043249634.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mukesh Kumar, MD has received a total of $8,515 in payments from pharmaceutical and medical device companies, with $918.80 received in 2024. These payments were reported across 438 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($8,119).
As a Medicare-enrolled provider, Kumar has provided services to 8,892 Medicare beneficiaries, totaling 11,843 services with total Medicare billing of $804,621. Data is available for 4 years (2020–2023), covering 127 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Kissimmee, FL
- Active Since 07/03/2006
- Last Updated 12/26/2012
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1043249634
Products in Payments
- Impella (Device) $1,309
- XARELTO (Drug) $1,013
- LEQVIO (Drug) $748.77
- LifeVest (Device) $526.44
- ENTRESTO (Drug) $472.97
- COREVALVE EVOLUT R (Device) $379.93
- Resolute (Device) $375.16
- Adempas (Drug) $230.89
- MICRA (Device) $174.75
- CoreValve Evolut (Device) $169.62
- VERQUVO (Drug) $156.89
- FARXIGA (Drug) $143.91
- Mitra Clip system (Device) $123.47
- BioMonitor (Device) $117.89
- WATCHMAN (Device) $117.81
- GENERAL - STENTS (Device) $116.71
- Ablation Therapy Hardware (Device) $115.57
- CAMZYOS (Drug) $114.11
- OPSUMIT (Drug) $110.68
- FFR LINK (Device) $108.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Kissimmee
Dr. Saqib Gowani, M.d, M.D
Cardiovascular Disease — Payments: $47,501
Cardiovascular Disease $47,501
Abdul Ezeldin, Md, MD
Cardiovascular Disease — Payments: $26,140
Cardiovascular Disease $26,140
Dr. Jooby John, M.d, M.D
Cardiovascular Disease — Payments: $10,559
Cardiovascular Disease $10,559
Carlos Zayas Torres, M.d, M.D
Cardiovascular Disease — Payments: $9,274
Cardiovascular Disease $9,274
Aamir Javaid, Md, MD
Cardiovascular Disease — Payments: $7,965
Cardiovascular Disease $7,965
Dr. Padma Raju, Md, MD
Cardiovascular Disease — Payments: $7,383
Cardiovascular Disease $7,383